The Times wants to hear from you. Reporters will review your submissions and use them to inform the stories we write. We may also contact you to hear more about your perspective. But we will never use ...

Among the more than 100 types of human papillomavirus (HPV), at least 14 are considered as 'high-risk' types which can cause ...

THE modern “office girlie” often finds herself juggling a demanding 9-to-5 job with a myriad of personal responsibilities.

On Monday, plaintiffs’ lawyers filed their opening brief asking the U.S. Court of Appeals for the Fourth Circuit to reinstate ...

Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer ...

Biological E. to produce Recbio's HPV9 vaccine in India, expanding global access to cervical cancer prevention.

IT is estimated that five million women did not attend their cervical screening appointment, in 2024 alone. This has prompted ...

Your child’s health is your top priority, and so protecting them from serious disease is incredibly important. That is why ...

This new book combines scrupulous scientific research with personal insights, offering an eye-opening look into HPV and its related cancers.

The Trump administration is ending U.S. support for immunizations abroad because of its opposition not only to foreign aid, ...

Uptake of human papillomavirus (HPV) vaccine remains low in many countries, although the bivalent and quadrivalent HPV vaccines given as a three-dose schedule are effective in the prevention of ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...